Codify — Article

California bill creates grant program to expand clinical laboratory training (AB 304)

Authorizes DHCAI, with CDPH coordination, to award grants to approved or accredited clinical lab training programs to grow the pipeline for lab scientists and technicians.

The Brief

AB 304 directs the Department of Health Care Access and Information (DHCAI), working with the State Department of Public Health (CDPH), to establish a grant program—subject to a legislative appropriation—to fund clinical training programs that prepare clinical laboratory scientists (CLS) or medical laboratory technicians (MLT). Eligible programs must be CDPH‑approved or accredited by a CDPH‑recognized accrediting body.

Grantees must expend awarded funds within three years.

The bill is narrowly focused: it creates an administrative vehicle for state dollars to expand laboratory training capacity and sets a single spending deadline. It leaves key implementation details—selection criteria, allowable uses, reporting, and oversight—to the administering agency and to the Legislature’s appropriation language, which will determine how effectively the program addresses location, capacity, and equity gaps in the lab workforce.

At a Glance

What It Does

The bill requires DHCAI, in coordination with CDPH and only upon legislative appropriation, to establish and run a grant program that funds training programs for CLS and MLTs. Eligible recipients are programs approved by CDPH or accredited by a CDPH‑recognized accreditor, and any grant must be spent within three years of award.

Who It Affects

Public and private institutions that run clinical laboratory training (community colleges, university programs, hospital-run programs, and private training providers) and their students; DHCAI and CDPH will share administrative roles; the state budget is the funding source via appropriation.

Why It Matters

California faces a growing shortage of laboratory professionals that constrains diagnostic capacity and public health responsiveness. This bill creates a targeted funding mechanism to expand training slots and infrastructure—but because it defers selection rules and reporting to the administering agency, the program’s design and impact will hinge on appropriation language and DHCAI implementation choices.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

AB 304 creates a narrowly tailored grant program to increase the number of trained clinical laboratory professionals in California. It does not itself appropriate money; it instructs DHCAI to stand up the program only if the Legislature provides funding.

The bill ties eligibility to existing regulatory approvals: programs must train CLS or MLTs and be either approved by CDPH or accredited by an accreditor CDPH recognizes.

Administration rests with DHCAI, with an explicit coordination role for CDPH. That means DHCAI will handle awarding and disbursing grants while CDPH will likely be asked to verify program approvals or accreditor status.

The statute does not prescribe award methodology, scoring criteria, or priorities (for example, whether to prioritize geographic areas, community colleges, partnerships with hospitals, or programs serving underserved students).A core operational constraint in the statute is the three‑year expenditure requirement: any grant must be spent within three years of receipt. Practically, that limits the program’s ability to fund long‑lead capital projects unless awards are structured to meet the timeline.

The bill also contains no explicit reporting, audit, or clawback rules: oversight and compliance responsibilities will depend on the terms DHCAI sets and the appropriation language accompanying any funding.Because the bill leaves several implementation details open—award size, allowable uses (faculty hires, clinical placements, equipment, student support), matching funds, and outcome metrics—much of how the program affects capacity, equity, and program quality will be decided during appropriation drafting and agency rulemaking or grant guidance. For prospective applicants, the law principally changes eligibility (CDPH approval or recognized accreditation) and imposes a spending deadline; it does not create new licensure pathways or alter educational standards set by CDPH.

The Five Things You Need to Know

1

The program only goes into effect if the Legislature appropriates money for it; the statute contains no funding line itself.

2

DHCAI administers the grants but must coordinate with CDPH; CDPH’s role appears limited to validating program approval or accreditor recognition.

3

Eligible grantees must both offer training for CLS or MLT roles and be CDPH‑approved or accredited by a CDPH‑recognized accreditor.

4

Grantees are required to expend awarded funds within three years of receipt; the bill imposes this single, strict spending deadline.

5

The statute does not specify selection criteria, allowable uses, reporting requirements, or enforcement mechanisms—those operational rules are left to DHCAI and the appropriation language.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Legislative findings on workforce shortage

This opening section states the Legislature’s finding that demand for clinical laboratory scientists and technicians has outpaced growth in training opportunities and that state action is needed to streamline pathways from training to employment. Practically, findings have no operational effect but frame legislative intent—useful if agencies interpret ambiguities in the grant program’s scope or priorities.

Article 8, Section 1330(a)

Establishes program and defines eligible programs

Subdivision (a) directs DHCAI, upon appropriation, to establish the grant program and sets eligibility criteria: recipients must offer CLS or MLT training and be CDPH‑approved or accredited by an accreditor CDPH recognizes. This ties eligibility to existing regulatory structures, which simplifies verification but may exclude informal or emerging training partnerships that lack CDPH approval or formal accreditation.

Article 8, Section 1330(b)

Grant authority and purpose

Subdivision (b) gives DHCAI explicit authority to award grants to eligible programs "for the purpose of training new clinical laboratory scientists or medical laboratory technicians." The text limits grants to capacity‑building for new trainees but does not define allowable budget line items, whether grants can fund operations, capital, student supports, or whether grants may require matching funds or performance milestones.

1 more section
Article 8, Section 1330(c)

Three‑year expenditure requirement

Subdivision (c) requires grantees to expend funds within three years of receipt. That creates a clear fiscal boundary DHCAI must enforce when designing awards; it also shapes what projects are feasible to fund. The statute does not specify remedies for failure to expend funds in time, leaving recovery, extension, or penalty policies to DHCAI’s grant terms or to appropriation conditions.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Enrolled and prospective CLS and MLT students — increased state funding can expand class seats, clinical placements, scholarships, or stipends that shorten time to qualification.
  • Community colleges and accredited training programs — eligible programs can access new revenue to hire faculty, expand lab facilities, or develop curriculum partnerships with hospitals.
  • Hospitals, clinical labs, and public health labs — adding graduates mitigates staffing shortages, reduces overtime and vacancy costs, and supports diagnostics and surveillance capacity.
  • Under‑resourced regions and safety‑net institutions — if DHCAI prioritizes equity in awards, rural and underserved communities could gain local training capacity that keeps workforce investments in‑state.

Who Bears the Cost

  • State general fund (or other appropriated source) — the program requires legislative appropriation, which competes with other budget priorities.
  • Department of Health Care Access and Information — DHCAI will absorb administrative workload for rulemaking, applicant review, monitoring, and compliance, potentially without dedicated funding unless the appropriation includes admin costs.
  • Training programs that receive grants — they must comply with the three‑year spending deadline and any reporting or matching obligations DHCAI imposes, which can strain smaller providers’ administrative capacity.
  • CDPH — expected to verify approvals and coordinate with DHCAI; CDPH may face additional review workload without statutory resources for faster approvals or accreditor recognition processes.

Key Issues

The Core Tension

The bill pits speed and flexibility—getting money into existing accredited programs to relieve workforce shortages quickly—against accountability and equitable expansion; giving DHCAI broad discretion can expedite awards but risks uneven geographic distribution, weak outcome measurement, and difficulty funding long‑lead capital needs under the three‑year spending rule.

The bill is minimalist: it creates authority to award grants but defers nearly all operational design to the Legislature’s appropriation language and to DHCAI rulemaking or grant guidance. That leaves several implementation risk points.

First, without predefined allowable uses or reporting requirements, DHCAI must decide whether funds target short‑term trainee supports (stipends, clinical placement costs), recurring program expenses (faculty salaries), or capital investments (lab equipment), each of which has different timelines and return on investment. Second, the three‑year expend‑by rule accelerates program delivery but may preclude funding major capital projects that require longer procurement or construction cycles unless awards are structured as multiyear commitments or smaller phased contracts.

Another tension arises from eligibility criteria tied to CDPH approval or accreditor recognition. This simplifies eligibility verification but risks excluding innovative community partnerships or nascent programs that could serve underserved students but lack formal accreditation.

The lack of explicit audit, recapture, or performance measures in the statute also raises accountability questions: agencies will need to build clawback clauses, outcome metrics (graduates, certification pass rates, placements), and equity priorities into grant terms or the appropriation bill to ensure public dollars expand capacity rather than subsidize programs with limited workforce outcomes.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.